New Pill May Kill the Flu Virus in Patients in 24 Hours

Japanese drug maker Shionogi has created an experimental compound delivered via a single-dose pill that has been shown to effectively kill the influenza (flu) virus in patients within a single day.

HHS Forms Conscience and Religious Freedom Division

The U.S. Department of Health and Human Services (HHS) has formed a new Conscience and Religious Freedom Division in the HHS Office for Civil Rights (OCR) to restore federal enforcement of U.S. laws that protect the fundamental and unalienable rights of conscience and religious freedom.

Higher-Potency Rabies IG Vaccine Receives FDA Approval

Grifols’ HyperRAB (rabies immune globulin [human]) has been approved by the U.S. Food and Drug Administration to treat rabies postexposure prophylaxis.

Medicare Costs Pose Rising Financial Burden on Older Adults

A recent study found that more than one-third of people with traditional Medicare spent at least 20 percent of their total income on out-of-pocket healthcare costs in 2013, and it is projected that number will increase to 42 percent by 2030.

Plasma Exchange with 5% Albumin Associated with Marked Stabilization of Brain Perfusion in Alzheimer’s

Plasma exchange with 5% albumin replacement was associated with marked stabilization of brain perfusion in patients with mild to moderate Alzheimer’s disease during a 21-week treatment period and reduced perfusion loss compared to control subjects at six-month follow up, according to findings from a sham-controlled Phase II clinical trial.

Mylan’s Ogivri Approved as Biosimilar to Herceptin

Mylan’s Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as a biosimilar to Genentech’s Herceptin (trastuzumab).

Study Finds 2017-18 Flu Vaccine More Protective Than Believed, Especially Among Children

With many reports about this year’s influenza (flu) vaccine ineffectiveness, a new study shows it is more effective than thought, especially among children.

Universal Flu Vaccine Begins Two-Year Clinical Trial

Researchers at the University of Oxford have begun a two-year clinical trial to test a universal influenza (flu) vaccine in more than 2,000 patients.

Study Shows Fever During Pregnancy Increases Risk of Autism at Birth

Researchers at Columbia University in New York have found children born to mothers who experience fever, especially multiple fevers, during the second trimester of pregnancy are at increased risk for developing autism spectrum disorder (ASD).

Subcutaneous Immune Globulin Effective as Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy

A Phase III, placebo-controlled study demonstrated both low-dose and high-dose therapy with a licensed, self-administered subcutaneous immune globulin product was efficacious and well-tolerated as maintenance treatment for patients with chronic inflammatory demyelinating polyneuropathy.